Billionaire Ken Griffin Reconsiders AI From Garbage to a Depressing Societal Force Atara ATRA Stock Consolidating at 958 Next Move Ahead 20260515 AXIL Brands AXIL Slips 226 Testing 658 Support 20260515 Larimar Therapeutics LRMR Stock Down 501 Support Test at 351 20260515 Market Digest Lowes Aptiv and Zoetis in Focus Portugals Meo Sues State for 82 Million Over Huawei 5G Ban Lowes Cautions on Shifting Consumer Behavior Signaling Potential Headwinds Dycom Industries Reports on Q1 2027 Performance in Recent Earnings Call BP Ousts Chair Albert Manifold Over Governance Lapses Shares Dip April Jobs Report Preview Labor Market Cooling Yet Resilient CTNM Q1 2026 Earnings Narrower Loss Beats Estimates as PreRevenue Biotech Maintains Discipline BXP Q1 2026 Earnings Massive EPS Beat Highlights Operational Resilience LTC Properties Inc Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter UiPath Q1 2026 Earnings Earnings Beat Driven by Cost Discipline Stock Rises NOC Q1 2026 Earnings Slight EPS Beat Amid Quiet Revenue Disclosure AFBI Q3 2023 Earnings Modest EPS of 025 Amid Quiet Quarter Concentra Group Holdings CON Holds Steady Near Key Resistance After Modest Gain TAL Education Group TAL Holds Near Support After Modest Gain Illumination Acquisition Corp I Units ILLUU Holds Steady Near 10 as SPAC Units Trade in Tight Range Winchester Bancorp WSBK Posts Slight Decline Holds Steady Above Key Support Level Entegris Inc ENTG Gains 296 as Semiconductor Materials Demand Holds Steady Core AI Holdings CHAI Inches Higher as Support Near 108 Holds Firm Nyxoah SA NYXH Q1 2026 Earnings NarrowerThanExpected Loss as Company Advances Sleep Apnea Platform JBS Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Market Conditions AZZ Inc Q1 2026 Earnings Strong Earnings Beat Amid Steady Operational Performance CLBT Q1 2026 Earnings EPS Surpasses Estimates by Nearly 19 ALAB Q1 2026 Earnings Strong EPS Beat Signals Robust Demand for AI Connectivity Solutions European Chipmaker XFAB Shares Surge Amid Social Media Buzz and Retail Trading Activity AVIR Q1 2026 Earnings NarrowerthanExpected Loss Boosts Investor Sentiment Ovid Therapeutics OVID Gains Nearly 4 as Shares Test Key Resistance